Cargando…

Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins

BACKGROUND: Patatins encoded by a multi-gene family are one of the major storage glycoproteins in potato tubers. Potato tubers have recently emerged as bioreactors for the production of human therapeutic glycoproteins (vaccines). Increasing the yield of recombinant proteins, targeting the produced p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoon-Sik, Lee, Yong-Hwa, Kim, Hyun-Soon, Kim, Mi-Sun, Hahn, Kyu-Woong, Ko, Jeong-Heon, Joung, Hyouk, Jeon, Jae-Heung
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335101/
https://www.ncbi.nlm.nih.gov/pubmed/18384693
http://dx.doi.org/10.1186/1472-6750-8-36
_version_ 1782152808365031424
author Kim, Yoon-Sik
Lee, Yong-Hwa
Kim, Hyun-Soon
Kim, Mi-Sun
Hahn, Kyu-Woong
Ko, Jeong-Heon
Joung, Hyouk
Jeon, Jae-Heung
author_facet Kim, Yoon-Sik
Lee, Yong-Hwa
Kim, Hyun-Soon
Kim, Mi-Sun
Hahn, Kyu-Woong
Ko, Jeong-Heon
Joung, Hyouk
Jeon, Jae-Heung
author_sort Kim, Yoon-Sik
collection PubMed
description BACKGROUND: Patatins encoded by a multi-gene family are one of the major storage glycoproteins in potato tubers. Potato tubers have recently emerged as bioreactors for the production of human therapeutic glycoproteins (vaccines). Increasing the yield of recombinant proteins, targeting the produced proteins to specific cellular compartments, and diminishing expensive protein purification steps are important research goals in plant biotechnology. In the present study, potato patatins were eliminated almost completely via RNA interference (RNAi) technology to develop potato tubers as a more efficient protein expression system. The gene silencing effect of patatins in the transgenic potato plants was examined at individual isoform levels. RESULTS: Based upon the sequence similarity within the multi-gene family of patatins, a highly conserved target sequence (635 nts) of patatin gene pat3-k1 [GenBank accession no. DQ114421] in potato plants (Solanum tuberosum L.) was amplified for the construction of a patatin-specific hairpin RNAi (hpRNAi) vector. The CaMV 35S promoter-driven patatin hpRNAi vector was transformed into the potato cultivar Desiree by Agrobacterium-mediated transformation. Ten transgenic potato lines bearing patatin hpRNA were generated. The effects of RNA interference were characterized at both the protein and mRNA levels using 1D and 2D SDS/PAGE and quantitative real-time RT-PCR analysis. Dependent upon the patatin hpRNAi line, patatins decreased by approximately 99% at both the protein and mRNA levels. However, the phenotype (e.g. the number and size of potato tuber, average tuber weight, growth pattern, etc.) of hpRNAi lines was not distinguishable from wild-type potato plants under both in vitro and ex vitro growth conditions. During glycoprotein purification, patatin-knockdown potato tubers allowed rapid purification of other potato glycoproteins with less contamination of patatins. CONCLUSION: Patatin-specific hpRNAi effectively suppressed the expression of a majority of patatin variants in potato tubers via the specific degradation of individual mRNAs of the patatin multi-gene family. More importantly, patatin-knockdown potato tubers appear to be an ideal host for the production of human therapeutic glycoproteins, because they eventually allow fast, easy purification of recombinant proteins, with less contamination from potato glycoprotein patatins.
format Text
id pubmed-2335101
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23351012008-04-25 Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins Kim, Yoon-Sik Lee, Yong-Hwa Kim, Hyun-Soon Kim, Mi-Sun Hahn, Kyu-Woong Ko, Jeong-Heon Joung, Hyouk Jeon, Jae-Heung BMC Biotechnol Research Article BACKGROUND: Patatins encoded by a multi-gene family are one of the major storage glycoproteins in potato tubers. Potato tubers have recently emerged as bioreactors for the production of human therapeutic glycoproteins (vaccines). Increasing the yield of recombinant proteins, targeting the produced proteins to specific cellular compartments, and diminishing expensive protein purification steps are important research goals in plant biotechnology. In the present study, potato patatins were eliminated almost completely via RNA interference (RNAi) technology to develop potato tubers as a more efficient protein expression system. The gene silencing effect of patatins in the transgenic potato plants was examined at individual isoform levels. RESULTS: Based upon the sequence similarity within the multi-gene family of patatins, a highly conserved target sequence (635 nts) of patatin gene pat3-k1 [GenBank accession no. DQ114421] in potato plants (Solanum tuberosum L.) was amplified for the construction of a patatin-specific hairpin RNAi (hpRNAi) vector. The CaMV 35S promoter-driven patatin hpRNAi vector was transformed into the potato cultivar Desiree by Agrobacterium-mediated transformation. Ten transgenic potato lines bearing patatin hpRNA were generated. The effects of RNA interference were characterized at both the protein and mRNA levels using 1D and 2D SDS/PAGE and quantitative real-time RT-PCR analysis. Dependent upon the patatin hpRNAi line, patatins decreased by approximately 99% at both the protein and mRNA levels. However, the phenotype (e.g. the number and size of potato tuber, average tuber weight, growth pattern, etc.) of hpRNAi lines was not distinguishable from wild-type potato plants under both in vitro and ex vitro growth conditions. During glycoprotein purification, patatin-knockdown potato tubers allowed rapid purification of other potato glycoproteins with less contamination of patatins. CONCLUSION: Patatin-specific hpRNAi effectively suppressed the expression of a majority of patatin variants in potato tubers via the specific degradation of individual mRNAs of the patatin multi-gene family. More importantly, patatin-knockdown potato tubers appear to be an ideal host for the production of human therapeutic glycoproteins, because they eventually allow fast, easy purification of recombinant proteins, with less contamination from potato glycoprotein patatins. BioMed Central 2008-04-03 /pmc/articles/PMC2335101/ /pubmed/18384693 http://dx.doi.org/10.1186/1472-6750-8-36 Text en Copyright © 2008 Kim et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kim, Yoon-Sik
Lee, Yong-Hwa
Kim, Hyun-Soon
Kim, Mi-Sun
Hahn, Kyu-Woong
Ko, Jeong-Heon
Joung, Hyouk
Jeon, Jae-Heung
Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title_full Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title_fullStr Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title_full_unstemmed Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title_short Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins
title_sort development of patatin knockdown potato tubers using rna interference (rnai) technology, for the production of human-therapeutic glycoproteins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335101/
https://www.ncbi.nlm.nih.gov/pubmed/18384693
http://dx.doi.org/10.1186/1472-6750-8-36
work_keys_str_mv AT kimyoonsik developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT leeyonghwa developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT kimhyunsoon developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT kimmisun developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT hahnkyuwoong developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT kojeongheon developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT jounghyouk developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins
AT jeonjaeheung developmentofpatatinknockdownpotatotubersusingrnainterferencernaitechnologyfortheproductionofhumantherapeuticglycoproteins